-
Mashup Score: 17
The Robert A. Winn Diversity In Clinical Trials Award Program Increasing diversity in clinical trials to reduce health disparities and improve health outcomes in all communities and populations. ⸻⸻⸻ AWARD PROGRAMS ⸻⸻⸻ WINN CDA WINN CIPP WINN CILA Winn CDA for early-stage investigator physicians will be
Source: diversityinclinicaltrials.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 122Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions - 17 day(s) ago
AbstractArtificial intelligence (AI) in oncology is advancing beyond algorithm development to integration into clinical practice. This review describes the current state of the field, with a specific focus on clinical integration. AI applications are structured according to cancer type and clinical domain, focusing on the four most common cancers and tasks of detection, diagnosis, and treatment. These applications encompass various data modalities, including imaging, genomics, and medical records. We conclude with a summary of existing challenges, evolving solutions, and potential future directions for the field.Significance:. AI is increasingly being applied to all aspects of oncology, where several applications are maturing beyond research and development to direct clinical integration. This review summarizes the current state of the field through the lens of clinical translation along the clinical care continuum. Emerging areas are also highlighted, along with common challenges, evo
Source: aacrjournals.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 16
NYU Langone’s New York Female Asian Nonsmoker Screening Study (FANSS) explores early detection of lung cancer in this high-risk population.
Source: med.nyu.eduCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 51
Summary:. The NCI director presents her vision of the National Cancer Plan as an integrated framework that can help drive innovation in cancer research to speed progress toward ending cancer as we know it.
Source: aacrjournals.orgCategories: General Medicine News, Oncologists1Tweet-
➡️ What is the #NationalCancerPlan? ➡️ How will this plan provide the framework to achieve the goal to “end cancer as we know it”? Check out perspective in @CD_AACR from @NCIDirector Dr. @KimrynRathmell. #AACR24 @AACR @OncoAlert https://t.co/K3fuih5Mft https://t.co/F6AG0FHELW https://t.co/vunoFHmxQP
-
-
Mashup Score: 25
Following disappointing Phase III results in less aggressive non-small cell lung cancer, AstraZeneca on Friday announced that Imfinzi improved progression-free and overall survival in patients with limited-stage small cell lung cancer.
Source: www.biospace.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 172024 AACR Runners for Research 5K Run/WalkI'm fundraising for American Association for Cancer Research and cancer research! - 24 day(s) ago
2024 AACR Runners for Research 5K Run/WalkEvent landing page for 2024 AACR Runners for Research 5K Run/Walk
Source: donate.aacr.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 21National Minority Quality Forum Announces 2024 “40 Under 40 Leaders in Minority Health” Award Recipients - National Minority Quality Forum - 1 month(s) ago
WASHINGTON, D.C. (March 18, 2024) —Today, National Minority Quality Forum (NMQF) announced its 40 Under 40 Leaders in Minority Health for 2024 that will receive recognition and awards at the NMQF Leadership Summit on Health Disparities and Health Braintrust during National Minority Health Month in April. Since 2016, NMQF has annually selected 40 health leaders […]
Source: nmqf.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 60
This year, nearly 250,000 Americans will be diagnosed with lung cancer, the leading cause of cancer death in the United States. During National Lung Cancer Awareness Month, we honor the resilient people who have faced this diagnosis, the loved ones who rally to their side, and the medical professionals who do all they…
Source: www.whitehouse.govCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 59
This year, nearly 250,000 Americans will be diagnosed with lung cancer, the leading cause of cancer death in the United States. During National Lung Cancer Awareness Month, we honor the resilient people who have faced this diagnosis, the loved ones who rally to their side, and the medical professionals who do all they…
Source: www.whitehouse.govCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1Engineering Multimodal Immunotherapies against Small-Cell Neuroendocrine Tumors | The Mark Foundation for Cancer Research - 6 month(s) ago
Small-cell neuroendocrine tumors (SCNTs) represent an aggressive group of difficult-to-treat tumors with shared characteristics that pose significant challenges in patient care.
Source: themarkfoundation.orgCategories: Latest Headlines, Oncologists1Tweet
Are you a trainee interested in #cancer, #clinicaltrials + #healthequity? Do not miss the chance to apply for the @DrRobWinn Diversity In Clinical Trials Award Program! Detail ⬇️. https://t.co/FI6BHs15z6 @AACR @AACRPres @DrRoyHerbstYale @FDAOncology @OncoAlert https://t.co/dMH8WQ2nG0